Carl Zeiss Meditec (ETR:AFX) Trading Up 0.2% – What’s Next?

Carl Zeiss Meditec AG (ETR:AFX)’s stock price rose 0.2% during mid-day trading on Monday . The company traded as high as €26.02 and last traded at €25.72. Approximately 169,544 shares were traded during trading, an increase of 80% from the average daily volume of 94,405 shares. The stock had previously closed at €25.68.

Carl Zeiss Meditec Stock Up 12.4%

The business’s 50 day simple moving average is €25.47 and its 200-day simple moving average is €33.38. The company has a market cap of $2.68 billion, a price-to-earnings ratio of 15.35, a price-to-earnings-growth ratio of 2.83 and a beta of 1.41. The company has a debt-to-equity ratio of 28.70, a quick ratio of 2.47 and a current ratio of 2.35.

Carl Zeiss Meditec Company Profile

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders. This segment also provides devices for general ophthalmological examination and care, including slit lamps, refractometers, tonometers, optical coherence tomography devices, and fundus cameras; and devices for functional diagnostics (perimeters), as well as digital products for storage, evaluation, and sharing of clinical data.